A new narrative review led by researchers at UCL and Birmingham Children’s Hospital has found there is a lack of evidence to demonstrate the effective use of continuous glucose monitors (CGMs) in people not living with diabetes (PNLD).
Kuros Biosciences Reports First Half of 2024 Results – Biotech Investments
Kuros Biosciences AG / Key word(s): Half Year Results 08-Aug-2024 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The